This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
|Articles|September 23, 2022
Cannabis Science Conference East 2022: Dr. Dustin Sulak Discusses Healthcare Professionals and Medical Cannabis Education
Author(s)Erin McEvoy
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the biggest challenge he encounters when educating other healthcare professionals on medical cannabis, both in the past and today.
Advertisement
Here, Dr. Dustin Sulak explains how the attitudes of healthcare professionals have changed over the years and how he has responded. He also notes a positive outcome he has seen recently when training clinicians on medical cannabis.
View the video for more of the discussion.
Advertisement
Related to this article
The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.
Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.
Advertisement
Advertisement